Compare Intuitive Surgical, Inc. (ISRG) vs Western Alliance Bancorporation (WAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Western Alliance Bancorporation — how do they compare? Intuitive Surgical, Inc. trades at $402.35 (market cap $141.75B), while Western Alliance Bancorporation trades at $82.32 (market cap $8.89B). The key difference: Intuitive Surgical, Inc. is far larger — about 15.9× Western Alliance Bancorporation's market cap, and Western Alliance Bancorporation pays a 2.06% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| ISRG | WAL | |
|---|---|---|
Market Cap | $141.75B | $8.89B |
Sector | Health | Financials |
52-Week High | $592.85 | $96.08 |
52-Week Low | $332.02 | $66.70 |
Enterprise Value | $136.53B | — |
Dividend Yield | — | 2.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $403.95, up 2.69% on the day, reflecting strong momentum. The stock exhibits bullish technical signals with support at $398 and resistance at $403. Fundamentally, revenue grew to $10.06B in 2025 with a net income margin of 28.45%, though valuation ratios like a P/E of 46.01 suggest premium pricing. Recent quarters show consistent earnings beats, with Q2 2026 EPS of $2.80 exceeding expectations. News highlights analyst upgrades and robust adoption of the da Vinci 5 system.
Outlook remains positive driven by innovation and market expansion, but high valuation and competitive pressures pose risks. The consensus price target of $518.10 implies significant upside, supported by 68% buy ratings from analysts. Key risks include reliance on U.S. procedure growth and rising competition from Medtronic and Johnson & Johnson. Long-term growth prospects appear solid if execution continues.
Western Alliance Bancorporation (WAL) trades at $82.18, up 2.11% today, with a neutral technical signal and bullish moving averages. The stock shows solid fundamentals with a P/E of 9.2 and net income margin of 25.43%, supported by recent earnings beats in Q4 2025 and Q1 2026. Recent developments include the launch of WA VenueX™ and recognition as Arizona's top bank by Forbes in 2026.
WAL presents a compelling investment case with strong analyst support (79% buy rating) and a consensus price target of $93.86, implying 14% upside. Risks include Q2 2026 EPS miss and negative operating cash flow in 2025, but improving 2026 projections and institutional interest suggest growth potential amid sector competition.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →
